Skip to main content
logo
Celltrion, Inc. (KRX:068270)
South Korea flag South Korea · Delayed Price · Currency is KRW
190,700
-600 (-0.31%)
At close: Aug 28, 2026

Revenue

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14
Biopharmaceutical Medicines Revenue
6.90T6.03T6.07T
Chemical Medicines Revenue
603.13B556.71B531.39B
Other Segments Revenue
6.66B6.74B5.82B
Adjustments to Revenue
-2,608.75B-2,434.23B-3,050.04B

Revenue by Geography

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14
Domestic Revenue
1.30T1.26T1.55T
Asia Revenue
339.73B309.00B192.46B
Europe Revenue
2.35T2.01T1.50T
North America Revenue
742.80B419.96B168.09B
Central and South America Revenue
173.71B161.78B140.96B

EBIT

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14
Biopharmaceutical Medicines Operating Income
1.15T1.22T1.20T
Chemical Medicines Operating Income
37.92B23.73B9.18B
Other Segments Operating Income
-1.76B86.19M505.60M
Adjustments to Operating Income
368.01B-70.39B-716.79B